Budweiser Exceeds Expectations in Q4 Earnings
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Feb 12 2026
0mins
Should l Buy BUD?
Source: Yahoo Finance
- Sales Growth: Budweiser's Q4 sales rose by 2.5%, with earnings per share increasing by 7.5%, both surpassing analyst expectations, indicating the company's resilience in a competitive market.
- Profit Guidance: The company set its 2026 operating profit guidance at a growth range of 4% to 8%, reflecting management's confidence in future performance, particularly amid challenges posed by commoditized products in the beer industry.
- Market Demand: Despite a 1.5% decline in volume for Q4, management noted that changing consumer preferences towards healthier lifestyles are reshaping the market, with expectations for volume boosts from major sporting events like the World Cup, particularly strong demand for Corona beer during the Winter Olympics.
- Brand Image Improvement: Budweiser is enhancing its brand image through high-profile Super Bowl ads, which are expected to continue boosting its influence in the U.S. market, especially as consumer affinity for the brand increases.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy BUD?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on BUD
Wall Street analysts forecast BUD stock price to rise
2 Analyst Rating
2 Buy
0 Hold
0 Sell
Moderate Buy
Current: 75.050
Low
75.00
Averages
80.00
High
85.00
Current: 75.050
Low
75.00
Averages
80.00
High
85.00
About BUD
Anheuser-Busch Inbev SA is a Belgium-based company. The Company is primarily engaged in the manufacturing of beer. The Company operates through six segments: North America, Middle Americas, South America, EMEA, Asia Pacific, Global Export and Holding companies. The Company's brand portfolio includes global brands, such as Budweiser, Corona and Stella Artois; international brands, including Beck's, Leffe and Hoegaarden, and local champions, such as Bud Light, Skol, Brahma, Antarctica, Quilmes, Victoria, Modelo Especial, Michelob Ultra, Harbin, Sedrin, Klinskoye, Sibirskaya Korona, Chernigivske, Cass and Jupiler. The Company's soft drinks business consists of both own production and agreements with PepsiCo related to bottling and distribution arrangements between its various subsidiaries and PepsiCo. Ambev, which is a subsidiary of the Company, is a PepsiCo bottler. Brands that are distributed under these agreements are Pepsi, 7UP and Gatorade.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Redemption Policy: Apollo Global Management has set a 5% quarterly redemption limit in its private credit fund, despite other firms relaxing their limits, aiming to maintain liquidity and bolster investor confidence, even as it faces redemption requests representing 11% of its assets.
- Market Risk Assessment: CEO Marc Rowan stated that software sector valuations are generally overstated, particularly in the context of rapid AI advancements, emphasizing the need for investors to have a clear understanding of their holdings to avoid potential risks and losses.
- Investment Scale and Returns: Last year, Apollo originated $310 billion in new investments, with 80% being investment-grade financing, serving major clients like Intel, BP, and Shell, indicating a robust investment strategy in a high-risk market.
- Role of Tech Companies in Debt Market: Rowan noted that the influence of technology companies in the debt market will continue to grow, predicting that in the next five years, major issuers of investment-grade debt will be dominated by large tech firms and banks, reflecting significant structural changes in the market.
See More
- Sysco Acquisition Update: Sysco is acquiring Restaurant Depot for $26 billion, aiming to enhance its supply chain efficiency across 700,000 restaurants, although it faces potential antitrust scrutiny that could complicate the deal.
- McCormick and Unilever Merger: McCormick announced a $44 billion merger with Unilever's food division, despite being valued at only $14 billion itself, indicating a strategic move to leverage scale and synergies, though past similar deals have often failed to deliver expected value.
- M&A Activity in Food Sector: The recent surge in mergers within the food industry highlights a market trend towards consolidation and economies of scale, yet historical data suggests that many large consumer brand mergers have not yielded positive outcomes, prompting investors to proceed with caution.
- Eli Lilly's Centessa Acquisition: Eli Lilly is acquiring Centessa Pharmaceuticals for $7.8 billion, focusing on expediting the market entry of a promising narcolepsy treatment, despite Centessa lacking commercial products, with success hinging on upcoming clinical trial results.
See More
- Sysco Acquisition Move: Sysco is acquiring Restaurant Depot for $26 billion, aiming to enhance its supply chain efficiency across its network of 700,000 restaurants, thereby solidifying its leadership position in the U.S. food service distribution market.
- McCormick and Unilever Merger: McCormick announced a merger with Unilever's food division valued at $44 billion, despite McCormick's market cap of only $14 billion, indicating a strategy to leverage scale and resource integration for improved profitability, though it faces integration risks.
- Market Reactions and Risks: Analysts express caution regarding both Sysco and McCormick's transactions, particularly with Sysco taking on $21 billion in new debt, which could impact its financial stability, while the success of McCormick's merger strategy remains to be seen.
- Eli Lilly Acquires Centessa: Eli Lilly announced the acquisition of Centessa Pharmaceuticals for $7.8 billion, focusing on rare disease treatments; if FDA approval is secured, it could tap into a $5 billion market, reflecting strong demand and investment willingness in the pharmaceutical sector.
See More
- Limited-Edition Packaging: Budweiser launches the largest limited-edition collectible pack ever, the Budweiser® FIFA World Cup™ Anniversary Pack, featuring 11 designs that pay tribute to every World Cup since 1986, aiming to attract consumers through nostalgia and enhance brand loyalty.
- Global Film Release: The new global film, 'The Big Drop,' set to the iconic anthem 'You'll Never Walk Alone,' showcases Budweiser bottles traversing continents, emphasizing the brand's deep connection with the World Cup and aiming to elevate brand awareness and market impact through stunning visuals.
- Digital Interactive Experience: Each limited-edition bottle features a QR code that unlocks exclusive digital content tied to its era, connecting fans to their favorite teams and providing immersive experiences and numerous prizes, further enhancing consumer engagement.
- Global Outdoor Campaign: Budweiser launches the 'Proudly on the Pitch' global outdoor campaign, utilizing archival imagery to showcase the brand's significant moments in World Cup history, aiming to attract a new generation of fans by revisiting iconic moments and solidifying its position in football culture.
See More
- Stock Price Movement: Ambev's shares fell by 1.35% today, closing at $2.93, with no specific company catalysts driving the decline, yet investors remain focused on analyst ratings and capital returns for future direction.
- Surge in Trading Volume: Trading volume reached 42.3 million shares, approximately 71% above the three-month average of 24.7 million shares, indicating increased market interest that could influence future price movements.
- Board Meeting Outcomes: During the board meeting on March 30, the approval of the 2025 profit allocation plan and suggestions for 2026 salary limits and bylaw amendments were made, alongside a capital increase driven by stock options, which may affect future shareholder returns.
- Analyst Ratings: As of late March, seven analysts maintained a consensus
See More
- Stock Performance: Ambev shares closed at $2.93, down 1.35%, with no specific company catalysts driving the decline, yet investors remain focused on analyst ratings and capital returns for future direction.
- Surge in Trading Volume: Trading volume reached 42.3 million shares today, approximately 71% above the three-month average of 24.7 million shares, indicating increased market interest that could influence future price movements.
- Analyst Ratings: As of late March, seven analysts maintained a consensus 'hold' rating on Ambev, with an average 12-month price target close to its current level, suggesting limited upside potential unless there is a significant boost in earnings momentum.
- Board Meeting Impact: During the board meeting on March 30, the approval of 2025 profit allocation and suggested 2026 salary limits was made, although these changes have not improved market sentiment, future changes in stock option compensation will need to be monitored.
See More











